Journal
JOURNAL OF BIOTECHNOLOGY
Volume 202, Issue -, Pages 3-11Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.jbiotec.2014.10.034
Keywords
E-cadherin; Epithelial mesenchymal-transition; Proteomics
Categories
Funding
- PON project [254/Ric]
Ask authors/readers for more resources
E-cadherin is the core protein of the epithelial adherens junction. Through its cytoplasmic domain, Ecadherin interacts with several signaling proteins; among them, alpha- and beta-catenins mediate the link of E-cadherin to the actin cytoskeleton. Loss of E-cadherin expression is a crucial step of epithelialmesenchymal transition (EMT) and is involved in cancer invasion and metastatization. In human tumors, down-regulation of E-cadherin is frequently associated with poor prognosis. Despite the critical role of E-cadherin in cancer progression, little is known about proteome alterations linked with its downregulation. To address this point, we investigated proteomics, biophysical and functional changes of epithelial breast cancer cell lines upon shRNA-mediated stable knockdown of E-cadherin expression (shEcad). shEcad cells showed a distinct proteomic signature including altered expression of enzymes and proteins involved in cytoskeletal dynamic and migration. Moreover, these results suggest that, besides their role in mechanical adhesion, loss of E-cadherin expression may contribute to cancer progression by modifying a complex network of pathways that tightly regulate fundamental processes as oxidative stress, immune evasion and cell metabolism. Altogether, these results extend our knowledge on the cellular modifications associated with E-cadherin down-regulation in breast cancer cells. (C) 2014 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available